Basket

Record was added to the basket

1.CAR-T cells for the treatment of relapsed/refractory multiple myeloma in 2022: efficacy and toxicity

CAR-T cells for the treatment of relapsed/refractory multiple myeloma in 2022: efficacy and toxicity : minireview / Martin Krejči ... [et al.] . Neoplasma : journal of experimental and clinical oncology. - ISSN 0028-2685 . - Vol. 69, no. 5 (2022), s. 1008-1018 : ilustr., obr., tab.

C 720
Request a copy DDS
DSD service
From the basket
Citation
Bookmark

Selected documents
Citation

citace PRO
article

For full functionality of this site it is necessary to enable JavaScript. Here are the instructions how to enable JavaScript in your web browser.